- Accesswire•4 hours agoBlog Coverage Eli Lilly Announced Acquisition of CoLucid; Adds Lasmiditan to the Pain Management Portfolio
LONDON, UK / ACCESSWIRE / January 19, 2017 / Active Wall St. blog coverage looks at the headline from Eli Lilly and Co. (NYSE: LLY ) and CoLucid Pharmaceuticals, Inc. (NASDAQ: CLCD ) as both companies ...
- The Wall Street Journal•12 hours ago
Big pharma appears to have rewritten the old value-investing mantra. Eli Lilly said Wednesday morning that it plans to acquire CoLucid Pharmaceuticals for $960 million in cash.
LLY : Summary for Eli Lilly and Company Common St - Yahoo Finance
Eli Lilly and Company (LLY)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Day's Range||77.06 - 77.62|
|52 Week Range||64.18 - 83.79|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||33.55|
|Dividend & Yield||2.08 (2.71%)|
|1y Target Est||N/A|